Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genentech
Biotech
Genentech scraps $2B cell therapy pact with Adaptive
The January 2019 pact with Adaptive Biotech was meant to see Genentech develop personalized cancer therapies based on Adaptive’s T-cell receptor tech.
Darren Incorvaia
Aug 18, 2025 2:40pm
Bicycle lays off staff as Genentech rides away from R&D pact
Aug 8, 2025 8:50am
Genentech cuts 87 more jobs in another round of HQ layoffs
Jul 23, 2025 10:33am
Genentech lays off 143 workers at South San Francisco campus
Jun 11, 2025 12:25pm
Genentech sticks 2nd molecular glue deal with Orionis worth $2B
May 21, 2025 8:30am
Genentech builds autoimmune Repertoire with $765M deal
Apr 23, 2025 7:00am
